Ligand Pharmaceuticals to Acquire XOMA Royalty for $39 Per Share
Ligand Pharmaceuticals (LGND) has agreed to acquire XOMA Royalty (XOMA) for $39 per share in cash, valued at approximately $739 million. The deal was unanimously approved by both companies' boards, signaling a strategic move to consolidate assets and potentially enhance shareholder value.
